Panama’s Ministry of Health is rolling out a new national drug procurement system designed to slash purchase times and improve supply at public hospitals. Officials announced the strategy this week, aiming to resolve chronic medication shortages that have plagued the health system for years. The plan hinges on a joint bulk-purchasing agreement with the nation’s social security agency.
The overhaul targets a core problem: bureaucratic delays. Under old rules, buying medicines could take between six and nine months. The new framework aims to compress that timeline to just two or three months. Nearly 400 medications are included in the first phase, with a focus on high-demand or hard-to-find drugs.
Eric Conte, Director of Pharmacies and Drugs for the Ministry of Health, outlined the urgency of the changes. He stated that accelerating the supply chain is critical for patient care.
“The first results of the new model should begin to be reflected in public pharmacies within two to three months, once the administrative processes are concluded and the awards are finalized,” Conte said. [Translated from Spanish]
Patients could see improved stock on pharmacy shelves by mid-year if the streamlined process works as intended. The immediate next step involves finalizing contracts with suppliers under the new rules.
Joint Purchasing and Legal Reforms Central to Strategy
A cornerstone of the model is the consolidated purchase agreement between the Ministry of Health (Panama) and the Caja de Seguro Social (CSS). By combining the purchasing power of both major public health institutions, the government expects to negotiate better prices and guarantee larger supply volumes. This approach to public procurement is common globally but marks a significant shift in Panama’s fragmented system.
Conte also highlighted legal modifications meant to prevent delays. The new rules limit administrative appeals during the bidding process. Companies dissatisfied with a bid award must now take their complaints directly to court instead of filing lengthy administrative challenges. This change seeks to prevent legal disputes from holding up the delivery of essential medicines.
Distribution hurdles remain, however. The ministry acknowledges persistent problems moving drugs from regional warehouses to remote health centers. In response, officials are upgrading transportation logistics and using a digital tracking tool. The system monitors national drug inventory in real time to identify and address shortages faster.
Focus on High-Cost Drugs and Reverse Auctions
A significant portion of the health budget is consumed by specialized medications. These drugs treat hospitalized patients, those in intensive care, and individuals with complex diseases like cancer or autoimmune disorders. Conte revealed these specialized pharmaceuticals can account for up to 60 percent of the annual drug expenditure due to their high cost and critical need.
To generate further savings, the ministry will pilot a reverse auction mechanism for approximately 50 medications. In this format, pre-qualified suppliers compete in a live, online environment by lowering their prices. The contract typically goes to the bidder offering the lowest price, fostering direct competition. This innovation aims to stretch public funds further while ensuring supply.
The success of this new model is vital for Panama’s broader seguro social/social security healthcare services. Systemic drug shortages have eroded public trust and complicated treatment plans nationwide. If effective, the faster, consolidated purchasing system could serve as a blueprint for reforming other areas of public health logistics. The coming months will provide the first real test of whether these changes can deliver tangible results for patients and pharmacies.